Atherosclerosis Monitoring and Atherogenicity Reduction Study

NCT01734707 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Carotid Atherosclerosis

Interventions

DIETARY_SUPPLEMENT: Allicor
DRUG: Placebo

Sponsor

Institute for Atherosclerosis Research, Russia